Near-Infrared Light May Identify Breast Cancer Patients Who Will Benefit Most from Chemotherapy

A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment.